Mobile fetal monitoring platform from Cerner wins FDA nod

11/14/2012 | Kansas City Star (Mo.), The

The FDA has cleared Cerner to market its FetaLink+ fetal monitoring system. The technology is designed to allow clinicians to use their iPads or iPhones to access fetal and maternal data in near-real time and make informed medical decisions.

View Full Article in:

Kansas City Star (Mo.), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ